SIC
AUPH icon

Salem Investment Counselors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Salem Investment Counselors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4K Hold
2,675
– – ﹤0.01% 630
2026
Q1 		$39.6K Buy
+2,675
New +$39.1K ﹤0.01% 644
2025
Q4 		– Sell
-3,598
Closed -$39.8K – 443
2025
Q3 		$39.8K Buy
3,598
+5
+0.1% +$55 ﹤0.01% 639
2025
Q2 		$30.4K Hold
3,593
– – ﹤0.01% 665
2025
Q1 		$28.9K Buy
3,593
+73
+2% +$591 ﹤0.01% 663
2024
Q4 		$31.6K Buy
3,520
+3
+0.1% +$24 ﹤0.01% 659
2024
Q3 		$25.8K Buy
3,517
+8
+0.2% +$50 ﹤0.01% 701
2024
Q2 		$20K Buy
3,509
+15
+0.4% +$79 ﹤0.01% 721
2024
Q1 		$17.5K Buy
3,494
+11
+0.3% +$75 ﹤0.01% 740
2023
Q4 		$31.3K Hold
3,483
– – ﹤0.01% 632
2023
Q3 		$27.1K Hold
3,483
– – ﹤0.01% 634
2023
Q2 		$33.7K Hold
3,483
– – ﹤0.01% 592
2023
Q1 		$38.2K Hold
3,483
– – ﹤0.01% 577
2022
Q4 		$15K Hold
3,483
– – ﹤0.01% 706
2022
Q3 		$26K Buy
3,483
+108
+3% +$935 ﹤0.01% 589
2022
Q2 		$34K Buy
3,375
+20
+0.6% +$224 ﹤0.01% 570
2022
Q1 		$42K Buy
3,355
+196
+6% +$3.03K ﹤0.01% 535
2021
Q4 		$72K Buy
3,159
+68
+2% +$1.61K ﹤0.01% 507
2021
Q3 		$68K Hold
3,091
– – ﹤0.01% 456
2021
Q2 		$40K Buy
3,091
+625
+25% +$7.96K ﹤0.01% 511
2021
Q1 		$32K Buy
2,466
+416
+20% +$6.04K ﹤0.01% 516
2020
Q4 		$28K Buy
2,050
+500
+32% +$7.28K ﹤0.01% 523
2020
Q3 		$23K Buy
1,550
+800
+107% +$11.6K ﹤0.01% 475
2020
Q2 		$12K Buy
+750
New +$12K ﹤0.01% 537

Other funds holding AUPH

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Salem Investment Counselors's AUPH Position: Q2 2026 in Review

Salem Investment Counselors held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 2,675 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #630.

Salem Investment Counselors first reported a position in AUPH in Q2 2020 and has held it in 24 quarters since. The position peaked at $72K in Q4 2021. 64 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Salem Investment Counselors held 2,675 shares of Aurinia Pharmaceuticals worth $45.4K as of Q2 2026.
  • Salem Investment Counselors left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #630 holding.
  • Salem Investment Counselors first reported a position in Aurinia Pharmaceuticals in Q2 2020 and has held it in 24 quarters since.
  • Salem Investment Counselors's Aurinia Pharmaceuticals position peaked at $72K in Q4 2021.
  • 64 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.